Zhikun Ma

1.6k total citations
38 papers, 1.1k citations indexed

About

Zhikun Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhikun Ma has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Zhikun Ma's work include Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (6 papers) and RNA modifications and cancer (5 papers). Zhikun Ma is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (6 papers) and RNA modifications and cancer (5 papers). Zhikun Ma collaborates with scholars based in China, United States and Poland. Zhikun Ma's co-authors include Xiaoshan Feng, Shegan Gao, Xiaohe Yang, Xiang Yuan, Amanda B. Parris, Shuoguo Li, Jinyu Kong, Jiong Li, Xiaojie Chen and Fuyou Zhou and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Zhikun Ma

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhikun Ma China 19 748 306 302 160 136 38 1.1k
S. Kannan India 18 571 0.8× 313 1.0× 251 0.8× 124 0.8× 190 1.4× 63 1.1k
Shu‐Chun Lin Taiwan 18 661 0.9× 281 0.9× 491 1.6× 80 0.5× 225 1.7× 28 1.2k
Patrick T. Hennessey United States 13 474 0.6× 118 0.4× 227 0.8× 96 0.6× 48 0.4× 15 775
Gabriella Aquino Italy 17 581 0.8× 207 0.7× 436 1.4× 127 0.8× 49 0.4× 44 1000
Huei‐Han Liou Taiwan 18 525 0.7× 186 0.6× 292 1.0× 67 0.4× 32 0.2× 37 809
Sofia Spyridonidou Greece 15 298 0.4× 232 0.8× 211 0.7× 51 0.3× 83 0.6× 31 663
Wenxia Meng China 17 342 0.5× 117 0.4× 234 0.8× 87 0.5× 153 1.1× 35 693
Beverly R. Wuertz United States 14 329 0.4× 495 1.6× 215 0.7× 89 0.6× 34 0.3× 43 935
CS Potten United Kingdom 14 455 0.6× 656 2.1× 195 0.6× 117 0.7× 24 0.2× 15 1.3k
Mingjing He China 16 443 0.6× 194 0.6× 95 0.3× 61 0.4× 78 0.6× 26 723

Countries citing papers authored by Zhikun Ma

Since Specialization
Citations

This map shows the geographic impact of Zhikun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhikun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhikun Ma more than expected).

Fields of papers citing papers by Zhikun Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhikun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhikun Ma. The network helps show where Zhikun Ma may publish in the future.

Co-authorship network of co-authors of Zhikun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhikun Ma. A scholar is included among the top collaborators of Zhikun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhikun Ma. Zhikun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagare, Piyusha P., et al.. (2024). Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells. Bioorganic Chemistry. 151. 107613–107613. 4 indexed citations
2.
Wang, Wenjin, Zhikun Ma, Gan Xiong, et al.. (2023). CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma. Advanced Science. 11(4). e2305002–e2305002. 13 indexed citations
3.
Wang, Ganping, Zhikun Ma, Gan Xiong, et al.. (2022). BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma. Molecular Therapy. 30(11). 3394–3413. 19 indexed citations
4.
Morris, Andrew J., et al.. (2022). Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt/β-catenin signaling pathway. Bioorganic Chemistry. 124. 105812–105812. 8 indexed citations
5.
Dong, Jiaqiang, Jiong Li, Yang Li, et al.. (2021). Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nature Communications. 12(1). 3974–3974. 87 indexed citations
6.
Zhang, Ming, Zhikun Ma, Bo Sun, et al.. (2021). FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Molecular Therapy. 29(8). 2583–2600. 71 indexed citations
7.
Ma, Zhikun, Amanda B. Parris, Meghan B. Davis, et al.. (2020). In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk. International Journal of Molecular Sciences. 21(9). 3095–3095. 11 indexed citations
8.
Shi, Yujie, Zhikun Ma, Qiong Cheng, et al.. (2020). FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118877–118877. 15 indexed citations
9.
Ma, Zhikun, Young Kim, Xiaoshan Feng, et al.. (2018). DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncology Reports. 40(3). 1632–1640. 11 indexed citations
10.
11.
Wang, Gongping, Shegan Gao, Ye Chen, et al.. (2017). Expression of ERO1L in gastric cancer and its association with patient prognosis. Experimental and Therapeutic Medicine. 14(3). 2298–2302. 21 indexed citations
12.
Zhao, Qingxia, Amanda B. Parris, Ming Zhao, et al.. (2017). FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice. Scientific Reports. 7(1). 11306–11306. 14 indexed citations
13.
Zhou, Fuyou, Chen Zhao, Zhikun Ma, et al.. (2016). Gastric cardia adenocarcinoma microRNA profiling in Chinese patients. Tumor Biology. 37(7). 9411–9422. 25 indexed citations
14.
Gao, Shegan, Shuoguo Li, Zhikun Ma, et al.. (2016). Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infectious Agents and Cancer. 11(1). 3–3. 241 indexed citations
15.
Zhou, Bo, Gongping Wang, Shegan Gao, et al.. (2016). Expression of GOLPH3 protein in colon cancer tissues and its association with the prognosis of patients. Oncology Letters. 12(5). 3936–3940. 19 indexed citations
16.
Yuan, Xiang, Jinyu Kong, Zhikun Ma, et al.. (2016). KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression. Neoplasia. 18(10). 594–609. 21 indexed citations
17.
Wang, Ying, et al.. (2015). The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma. International Journal of Oncology. 47(5). 1819–1828. 35 indexed citations
18.
Feng, Xiaoshan, Ying Wang, Zhikun Ma, et al.. (2014). MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. BMC Cancer. 14(1). 633–633. 35 indexed citations
19.
Yang, Shihe, Zhikun Ma, Dharmalingam Subramaniam, et al.. (2012). p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription. PLoS ONE. 7(8). e43564–e43564. 24 indexed citations
20.
Kim, Young Mi, et al.. (2011). Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. Oncology Letters. 2(6). 1077–1081. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Kannan Breakdown of academic impact, for papers by Shu‐Chun Lin Breakdown of academic impact, for papers by Patrick T. Hennessey Breakdown of academic impact, for papers by Gabriella Aquino Breakdown of academic impact, for papers by Huei‐Han Liou Breakdown of academic impact, for papers by Sofia Spyridonidou Breakdown of academic impact, for papers by Wenxia Meng Breakdown of academic impact, for papers by Beverly R. Wuertz Breakdown of academic impact, for papers by CS Potten Breakdown of academic impact, for papers by Mingjing He
Rankless by CCL
2026